18F‐fluoromisonidazole uptake in advanced stage non‐small cell lung cancer: A voxel‐by‐voxel PET kinetics study

Purpose The aim of this study was to determine the relative abilities of compartment models to describe time‐courses of 18F‐fluoromisonidazole (FMISO) uptake in tumor voxels of patients with non‐small cell lung cancer (NSCLC) imaged using dynamic positron emission tomography. Also to use fits of the best‐performing model to investigate changes in fitted rate‐constants with distance from the tumor edge. Methods Reversible and irreversible two‐ and three‐tissue compartment models were fitted to 24 662 individual voxel time activity curves (TACs) obtained from tumors in nine patients, each imaged twice. Descriptions of the TACs provided by the models were compared using the Akaike and Bayesian information criteria (AIC and BIC). Two different models (two‐ and three‐tissue) were fitted to 30 measured voxel TACs to provide ground‐truth TACs for a statistical simulation study. Appropriately scaled noise was added to each of the resulting ground‐truth TACs, generating 1000 simulated noisy TACs for each ground‐truth TAC. The simulation study was carried out to provide estimates of the accuracy and precision with which parameter values are determined, the estimates being obtained for both assumptions about the ground‐truth kinetics. A BIC clustering technique was used to group the fitted rate‐constants, taking into consideration the underlying uncertainties on the fitted rate‐constants. Voxels were also categorized according to their distance from the tumor edge. Results For uptake time‐courses of individual voxels an irreversible two‐tissue compartment model was found to be most precise. The simulation study indicated that this model had a one standard deviation precision of 39% for tumor fractional blood volumes and 37% for the FMISO binding rate‐constant. Weighted means of fitted FMISO binding rate‐constants of voxels in all tumors rose significantly with increasing distance from the tumor edge, whereas fitted fractional blood volumes fell significantly. When grouped using the BIC clustering, many centrally located voxels had high‐fitted FMISO binding rate‐constants and low rate‐constants for tracer flow between the vasculature and tumor, both indicative of hypoxia. Nevertheless, many of these voxels had tumor‐to‐blood (TBR) values lower than the 1.4 level commonly expected for hypoxic tissues, possibly due to the low rate‐constants for tracer flow between the vasculature and tumor cells in these voxels. Conclusions Time‐courses of FMISO uptake in NSCLC tumor voxels are best analyzed using an irreversible two‐tissue compartment model, fits of which provide more precise parameter values than those of a three‐tissue model. Changes in fitted model parameter values indicate that levels of hypoxia rise with increasing distance from tumor edges. The average FMISO binding rate‐constant is higher for voxels in tumor centers than in the next tumor layer out, but the average value of the more simplistic TBR metric is lower in tumor centers. For both metrics, higher values might be considered indicative of hypoxia, and the mismatch in this case is likely to be due to poor perfusion at the tumor center. Kinetics analysis of dynamic PET images may therefore provide more accurate measures of the hypoxic status of such regions than the simpler TBR metric, a hypothesis we are presently exploring in a study of tumor imaging versus histopathology.

[1]  S. Nehmeh,et al.  Quantitative analysis of blood-borne 18F-FMISO metabolites in cancer patients by HPLC using an integrated high-sensitivity coincidence detector , 2015 .

[2]  P. Marsden,et al.  Interstitial diffusion and the relationship between compartment modelling and multi-scale spatial-temporal modelling of 18F-FLT tumour uptake dynamics , 2014, Physics in medicine and biology.

[3]  A. Kjaer,et al.  Kinetic modeling in PET imaging of hypoxia. , 2014, American journal of nuclear medicine and molecular imaging.

[4]  Paul K Marsden,et al.  18F-FLT uptake kinetics in head and neck squamous cell carcinoma: a PET imaging study. , 2014, Medical physics.

[5]  P. Lambin,et al.  Hypoxia imaging with [¹⁸F]HX4 PET in NSCLC patients: defining optimal imaging parameters. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  Johannes A Langendijk,et al.  PET Imaging of Tumor Hypoxia Using 18F-Fluoroazomycin Arabinoside in Stage III–IV Non–Small Cell Lung Cancer Patients , 2013, The Journal of Nuclear Medicine.

[7]  Claudio Cobelli,et al.  Tracer Kinetics in Biomedical Research: From Data to Model , 2013 .

[8]  Paul E Kinahan,et al.  Quantitative assessment of dynamic PET imaging data in cancer imaging. , 2012, Magnetic resonance imaging.

[9]  John L. Humm,et al.  Pharmacokinetic Analysis of Hypoxia 18F-Fluoromisonidazole Dynamic PET in Head and Neck Cancer , 2010, Journal of Nuclear Medicine.

[10]  Ellen Yorke,et al.  Modeling acute and chronic hypoxia using serial images of F18-FMISO PET. , 2009, Medical physics.

[11]  Steen Jakobsen,et al.  Can hypoxia-PET map hypoxic cell density heterogeneity accurately in an animal tumor model at a clinically obtainable image contrast? , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  Rosemary A. Renaut,et al.  DG – PET parametric imaging by total variation minimization , 2009 .

[13]  John L. Humm,et al.  Evaluation of a compartmental model for estimating tumor hypoxia via FMISO dynamic PET imaging , 2008, Physics in medicine and biology.

[14]  Vicky Goh,et al.  Acute tumor vascular effects following fractionated radiotherapy in human lung cancer: In vivo whole tumor assessment using volumetric perfusion computed tomography. , 2007, International journal of radiation oncology, biology, physics.

[15]  Michael Brady,et al.  A model to simulate tumour oxygenation and dynamic [18F]-Fmiso PET data , 2006, Physics in medicine and biology.

[16]  Daniela Thorwarth,et al.  Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer , 2005, BMC Cancer.

[17]  Mark Muzi,et al.  Kinetic modeling of 3'-deoxy-3'-fluorothymidine in somatic tumors: mathematical studies. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  Matthias Reimold,et al.  Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  S. Ametamey,et al.  Assessment of hypoxia and perfusion in human brain tumors using PET with 18F-fluoromisonidazole and 15O-H2O. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  David R. Anderson,et al.  Multimodel Inference , 2004 .

[21]  M. V. van Herk,et al.  Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy. , 2002, International journal of radiation oncology, biology, physics.

[22]  A A Lammertsma,et al.  Image-derived input functions for determination of MRGlu in cardiac (18)F-FDG PET scans. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[23]  C Cobelli,et al.  Kinetic modeling of [(18)F]FDG in skeletal muscle by PET: a four-compartment five-rate-constant model. , 2001, American journal of physiology. Endocrinology and metabolism.

[24]  C C Ling,et al.  Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. , 2000, International journal of radiation oncology, biology, physics.

[25]  M. Graham,et al.  A modeling approach for quantifying tumor hypoxia with [F-18]fluoromisonidazole PET time-activity data. , 1995, Medical physics.

[26]  D. Feng,et al.  Models for computer simulation studies of input functions for tracer kinetic modeling with positron emission tomography. , 1993, International journal of bio-medical computing.

[27]  T. Jones,et al.  Spectral Analysis of Dynamic PET Studies , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[28]  K. Krohn,et al.  Radiolabelled fluoromisonidazole as an imaging agent for tumor hypoxia. , 1989, International journal of radiation oncology, biology, physics.

[29]  C. Cobelli,et al.  Parameter and structural identifiability concepts and ambiguities: a critical review and analysis. , 1980, The American journal of physiology.

[30]  M. Reivich,et al.  THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT 1 , 1977, Journal of neurochemistry.

[31]  H. Akaike A new look at the statistical model identification , 1974 .

[32]  J. Wolfowitz,et al.  On a Test Whether Two Samples are from the Same Population , 1940 .

[33]  R. Muschel,et al.  Dual inhibition of the PI3K/mTOR pathway increases tumor radiosensitivity by normalizing tumor vasculature. , 2012, Cancer research.

[34]  C Clifton Ling,et al.  Modeling acute and chronic hypoxia using serial images of 18F-FMISO PET. , 2009, Medical physics.

[35]  Rakesh K. Jain,et al.  Transport of molecules across tumor vasculature , 2004, Cancer and Metastasis Reviews.

[36]  K L Lindsley,et al.  Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography. , 1995, International journal of radiation oncology, biology, physics.

[37]  T W Griffin,et al.  Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole. , 1992, International journal of radiation oncology, biology, physics.